Image Coronavirus Vaccine & Biologics Candidates – A Global Analysis

Coronavirus Vaccines & Biologics Candidates – A Global Analysis

$6,037$12,677

Featuring 115 vaccine, 20 stem cell therapies and 22 antibody candidates, IMAPAC brings to you the Coronavirus Vaccine & Biologics Candidates – A Global Analysis report which brings together over 200 organizations working on a panacea for the COVID-19 pandemic. It comprises of exclusive interviews with industry experts from Novavax, International Vaccine Institute, EpiVax and more, industry surveys and comprehensive secondary research. For more information, send us a request for the sample insights.

KEY TAKEAWAYS
  • Recognize key players involved in response to coronavirus-specific diseases.
  • Identify vaccine manufacturers region-wise.
  • Pinpoint regions experiencing innovation to guide market focus for co-development, technology/service customer base.
  • Exclusive interviews with industry experts from Novavax, International Vaccine Institute, EpiVax and more, industry surveys and comprehensive secondary research.
Clear
 
product details
  • 1Table of Contents
  • 2Companies Mentioned
  • 3User Access

Section 1: Introduction

  • Preface
  • Report Scope & Data Coverage
  • IMAPAC’s Research Methodology

Section 2: COVID-19 Pipeline Analysis

  • Company Overview
  • Product Portfolio
  • Certification
  • R&D Pipeline Analysis
  • Innovation
  • Therapeutic Focus Areas
  • Partnerships & Collaborations
  • Interview
  • Industry News & Updates
  • SWOT Analysis
  • References

Section 3: Our Other Reports

  • Bibiliography
  • Disclaimer
  • About Us
  • Our Other Reports

BioPharmas

  • Adaptvac
  • AJ Vaccines
  • Altimmune
  • Applied DNA Sciences
  • Arcturus Therapeutics
  • Batavia Biosciences
  • Beijing Advaccine
    Bionet Asia
  • Biontech
    Bravovax
  • CC Pharming
  • Clover Pharmaceuticals
  • Codegenix
  • Curevac
  • Dynavax
  • Epivax
  • Flow Pharma Inc.
  • Fosun Pharma
  • GSK
  • Generex
  • Geovax
  • Gilead Sciences
  • Greffes
  • Heat Biologics
  • IBIO
  • Immunoprecise
  • Inovio Pharmaceuticals
  • Janssen Pharmaceuticals
  • Johnson & Johnson
  • Medicago
  • Moderna
  • Novavax
  • Oncogen
  • Pfizer
  • RNACure Biopharma
  • Reithera
  • Sanofi Pasteur
  • Serum Institute of India
  • Sinovac
  • Takis Biotech
  • Themis Biosciences
  • Tonix Pharma
  • Vaxart
  • Vaxil Bio
  • Zydus Cadila

Academic & Research Institutes

  • Beijing Insitute of Biological Products
  • Duke-NUS Medical School
  • Fudan University
  • Geran Centre for Research
  • Imperial College of London
  • Institute Pasteur
  • Karolinska University
  • Migal Research Institute
  • Shanghai Jiaotong University
  • The Peter Doherty Institute For Infection and Immunity
  • University of Oxford
  • University of Hong Kong
  • University of Queensland

Single - User Access

This license grants the right of use of the purchased report to a single recipient only. You may access the material on your computer, as and when required, for your own personal use.

Multi - User Access

Upto 3 users: This license grants the right of use of the purchased report by upto 3 users of the same firm/enterprise.

Corporate Access

Unlimited user access (Within your organization): This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the number of users.

chat
Get In Touch

    padlock

    By clicking the "Submit" button, you are agreeing to IMAPAC's Privacy Policy.

    bag